Dear Friends and Colleagues,
I am pleased to share the Summer 2016 edition of the CRF Skirball Center for Innovation’s MedTech Quarterly with you. In this issue, we discuss the development of the newly FDA-approved bioresorbable vascular scaffold (BVS), as well as the diagnosis, therapeutic interventions and innovations in the field of peripheral vascular disease.
This edition features video interviews with leading experts such as Dr. Greg Kaluza, Director of Research at the CRF Skirball Center for Innovation; Dr. Gregg Stone, Professor of Medicine at Columbia University and Co-Director of Research and Education at CRF; Dr. Mahmood Razavi, interventional radiologist at St. Joseph Heritage Medical Group; Dr. Michael Jaff, Medical Director at Massachusetts General Hospital’s Vascular Center; and Dr. William Gray, President of the Lankenau Heart Institute.
I would like to thank everyone involved in the production of these videos and the editorial group led by Samantha Stone. For more information on the CRF Skirball Center for Innovation, please visit our website or our LinkedIn page.
Juan F. Granada, MD
Executive Director and Chief Innovation Officer
Featured Emerging Technology
Dr. Gregg Stone explains the exciting breakthrough of the newly FDA-approved bioresorbable vascular scaffold.
The bioresorbable scaffold: How did we get here and where are we going? A research perspective by Dr. Greg Kaluza.
Drivers and Movers
Below the Knee (BTK) revascularization: Dr. Mahmood Razavi reveals the dangers of what we cannot yet see.
Dr. Michael Jaff explores theoretical approaches to monitoring vascular integrity.
Dr. William Gray discusses the approach to the diseased SFA-varied pathologies and how diverse technologies make customization essential.